| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 1,052 | 929 | +13.2% |
| EBITDA | 164 | 133 | +23.5% |
| EBITDA margin | 15.6% | 14.3% | +1.3 pts |
| Profit before tax | 107 | 85.7 | +25.4% |
| Net profit | 91.7 | 74.4 | +23.4% |
| EPS | ₹10.17 | ₹8.24 | +23.4% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 6,156 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 662 | 581 | 422 | 246 | 208 | ||
| 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | ||
| 0.0 | 0.0 | 0.0 | 3.4 | 3.0 | ||
| 5,494 | — | — | — | — | ||
| 5,479 | 5,268 | 4,320 | 3,163 | 4,045 | ||
| — | +21.9% | +36.6% | −21.8% | — | ||
| 1,078 | 1,076 | 596 | 283 | 643 | ||
| 19.7% | 20.4% | 13.8% | 8.9% | 15.9% | ||
| 707 | 752 | 321 | 15.7 | 395 | ||
| 644 | 681 | 304 | 31.9 | 342 | ||
| 11.7% | 12.9% | 7.1% | 1.0% | 8.5% | ||
| ₹71.34 | ₹75.47 | ₹33.74 | ₹3.53 | ₹37.90 | ||
| — | +123.7% | +854.7% | −90.7% | — | ||
| — | 656 | 604 | 341 | 328 | ||
| — | −497 | −393 | −272 | −244 | ||
| 158 | 158 | 211 | 69.2 | 84.2 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 6,155.7 | |
| - Cash, Equiv & ST Investments | 208.3 | 246.2 | 421.5 | 581.3 | 661.9 | |
| + Minority Interest | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | |
| + Total Debt | 3.0 | 3.4 | 0.0 | 0.0 | 0.0 | |
| Enterprise Value | — | — | — | — | 5,494.3 | |
| Revenue | 4,045.2 | 3,163.0 | 4,319.9 | 5,267.6 | 5,479.1 | |
| Growth %, YoY | — | -21.8 | +36.6 | +21.9 | — | |
| EBITDA | 643.1 | 282.9 | 595.6 | 1,076.2 | 1,078.2 | |
| Margin % | 15.90 | 8.94 | 13.79 | 20.43 | 19.68 | |
| EBIT | 395.0 | 15.7 | 320.9 | 751.7 | 707.3 | |
| Net Income | 342.0 | 31.9 | 304.4 | 681.0 | 643.6 | |
| Margin % | 8.45 | 1.01 | 7.05 | 12.93 | 11.75 | |
| EPS, Adj (current shares) | 37.90 | 3.53 | 33.74 | 75.47 | 71.34 | |
| Growth %, YoY | — | -90.7 | +854.7 | +123.7 | — | |
| Cash from Operations | 328.3 | 341.3 | 603.6 | 655.7 | — | |
| Capital Expenditures | -244.1 | -272.1 | -393.1 | -497.3 | — | |
| Free Cash Flow | 84.2 | 69.2 | 210.6 | 158.4 | 158.4 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Sharda Cropchem (NSE: SHARDACROP) had a market capitalisation of ₹6,000 crore at the 30 October 2026 close (₹665.05 a share), a PE ratio of 9.3 on the last four quarters' profit and a price-to-book ratio of 1.85. In FY26 its consolidated net profit was ₹681 crore on revenue of ₹5,268 crore; in Q2 FY27 (July–September 2026) it was ₹91.8 crore, up 23.5% year on year. It had no borrowings on 30 September 2026. Promoters held 74.82% of the shares on 30 September 2026.
Sharda Cropchem's PE ratio is 9.3 at the 30 October 2026 close (₹665.05 a share): a market capitalisation of ₹6,000 crore divided by consolidated net profit of ₹644 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹681 crore) it is 8.8.
Sharda Cropchem's debt-to-equity ratio was 0.00 on 30 September 2026: no borrowings against total equity of ₹3,250 crore. A year earlier, on 30 September 2025, it was 0.00.
Sharda Cropchem's net worth — shareholders' equity in its consolidated balance sheet — was ₹3,250 crore on 30 September 2026, up 21.5% from ₹2,675 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹6,000 crore at the 30 October 2026 close.
Sharda Cropchem's price-to-book (PB) ratio is 1.85 at the 30 October 2026 close: a market capitalisation of ₹6,000 crore divided by shareholders' equity (book value) of ₹3,250 crore on 30 September 2026. That is a book value of ₹360.23 per share against a share price of ₹665.05.
In FY26, Sharda Cropchem's return on equity (ROE) was 24.2% and its return on capital employed (ROCE) was 24.5%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 12.9% and ROCE 12.4%.
Sharda Cropchem's book value per share was ₹360.23 on 30 September 2026: shareholders' equity of ₹3,250 crore divided by the 9.02 crore shares in issue, up 21.5% from ₹296.55 a year earlier. The share price at the 30 October 2026 close was ₹665.05.
Sharda Cropchem's market capitalisation was ₹6,000 crore at the 30 October 2026 close: 9.02 crore shares at ₹665.05 each.
Yes. Sharda Cropchem had no borrowings on 30 September 2026 (consolidated balance sheet), and it held ₹662 crore of cash, bank balances and current investments.
Sharda Cropchem's basic earnings per share (EPS) were ₹75.47 in FY26, against ₹33.74 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹71.34.
Sharda Cropchem's dividend yield is 2.26% at the 30 October 2026 close: dividends of ₹15 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹665.05. They were ₹9 on 7 August 2026 and ₹6 on 6 February 2026 (interim).
In FY26, Sharda Cropchem generated ₹656 crore of cash from operations and spent ₹497 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹158 crore. In FY25 it was ₹211 crore.
Sharda Cropchem has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
In 2026, Sharda Cropchem has declared two dividends totalling ₹15 a share: ₹6 (interim) with record date 6 February 2026 and ₹9 with record date 7 August 2026.
Promoters held 74.82% of Sharda Cropchem on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
Sharda Cropchem's latest results are for Q2 FY27 (July–September 2026), filed on 30 October 2026: consolidated net profit ₹91.8 crore, up 23.5% from ₹74.3 crore in Q2 FY26; revenue from operations ₹1,052 crore, up 13.2% year on year.
On 30 September 2026, Sharda Cropchem's shares were held by promoters 74.82%, foreign portfolio investors (FII/FPI) 3.27%, domestic institutions (DII) 9.22% (including mutual funds at 8.91%) and retail and other non-institutional investors 12.69%. Over the year, FII holding was down 1.99 percentage points from 5.26% and DII holding was down 0.04 percentage points from 9.26%.
At the 30 October 2026 closing prices, on FY26 net profit, Sharda Cropchem's PE ratio is 8.8, the lowest of the four: UPL 22.6, PI Industries 24.5 and Styrenix Performance Materials 16.9, a peer average of 21.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.
In FY26, Sharda Cropchem earned net profit of ₹681 crore on revenue of ₹5,268 crore, against ₹1,922 crore on ₹51,839 crore for UPL. Sharda Cropchem's operating margin was 14.3% (UPL 11.6%) and its return on equity 24.2% (UPL 6.0%). At the 30 October 2026 close, Sharda Cropchem's market capitalisation was ₹6,000 crore against ₹43,378 crore for UPL, and its PE ratio on FY26 profit 8.8 against 22.6.
In FY26 (April 2025–March 2026), Sharda Cropchem's consolidated net profit was ₹681 crore, up 123.7% from ₹304 crore in FY25, on revenue from operations of ₹5,268 crore (up 21.9%). Over three years, from FY23, net profit was up 99.1%.
On FY26 consolidated figures, against UPL, PI Industries and Styrenix Performance Materials: Sharda Cropchem's operating margin of 14.3% is the second highest of the four (UPL 11.6%, PI Industries 19.3%, Styrenix Performance Materials 6.7%; peer average 12.5%); its return on equity of 24.2% is the highest of the four (UPL 6.0%, PI Industries 12.2%, Styrenix Performance Materials 14.4%; peer average 10.9%); its revenue growth over three years of 9.2% a year is the second highest of the four (UPL −1.1% a year, PI Industries 1.1% a year, Styrenix Performance Materials 13.2% a year; peer average 4.4% a year).
From Sharda Cropchem's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.